Epidemiology of Schizophrenia

Textbook in Psychiatric Epidemiology: Third Edition

Volumn , Issue , 2011, Pages 263-287

  Eaton, William W ^a   Chen, Chuan Yu ^b   Bromet, Evelyn J ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

Biological risk factors and genes; Clinical cohort studies diagnoses derived from semi structured examinations, as Present State Examination (PSE) and Schedules for Clinical Assessment in Neuropsychiatry (SCAN); Clinical diagnoses, basis of epidemiological studies and case registries; Demographic correlates age and sex, force of morbidity of schizophrenia peaks in young adulthood; Epidemiology of schizophrenia; Psychotic disorders schizophrenia, being debilitating and persistent; Research on schizophrenia integrating suggestions from key studies and reviews; Results, linking schizophrenia to autoimmune disease clinical and laboratory study of autoimmune processes in schizophrenia; Social risk factors, and ethnicity ethnic status, shared history with others; WHO followup of schizophrenia after 5 years

Indexed keywords

EID: 84860889878     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470976739.ch16     Document Type: Chapter

References (204)

1. Yolles, S.F. and Kramer, M. (1969) Vital statistics, in The Schizophrenic Syndrome (ed. L. Bellak), Grune & Stratton, New York, pp. 66-113.
2. Bromet, E.J., Dew, M.A. and Eaton, W.W. (2002) Epidemiology of psychosis with special reference to Schizophrenia, in Textbook in Psychiatric Epidemiology, 2nd edn, (eds M.T. Tsuang and M. Tohen), Wiley-Liss, New York, pp. 365-387.
3. Eaton, W.W. and Chen, C.-Y. (2006) Epidemiology of schizophrenia, in The American Psychiatric Publishing Textbook of Schizophrenia (eds J.A. Lieberman, T.S. Stroup and D.O. Perkins), American Psychiatric Publishing, Inc., Washington, DC, pp. 17-38.
4. Tandon, R., Keshavan, M.S. and Nasrallah, H.A. (2008) Schizophrenia, 'just the facts' what we know in 2008. 2. Epidemiology and etiology. Schizophr. Res., 102, 1-18.
5. Kramer, M. (1969) Cross-national study of diagnosis of the mental disorders: origin of the problem. Am. J. Psychiatry, 125, 1-11.
6. Wing, J., Birley, J., Cooper, J. et al. (1967) Reliability of a procedure for measuring and classifying 'present psychiatric state'. Br. J. Psychiatry, 113, 499-515.
7. Wing, J.K., Babor, T., Brugha, T. et al. (1990) SCAN: Schedules for clinical assessment in neuropsychiatry. Arch. Gen. Psychiatry, 47, 589-593.
8. Williams, J.B.W., Gibbon, M., First, M.B. et al. (1992) The structured clinical interview for DSMIII- R (SCID): II. Multisite test-retest reliability. Arch. Gen. Psychiatry, 49, 630-636.
9. Robins, L.N., Helzer, J.E., Croughan, J. and Ratcliff, K.S. (1981) National Institute of Mental Health Diagnostic Interview Schedule: its history, characteristics, and validity. Arch. Gen. Psychiatry, 38, 381-389.
10. Wittchen, H.U., Robins, L.N., Cottler, L.B. et al. (1991) Cross-cultural feasibility, reliability and sources of variance of the composite international diagnostic interview (CIDI). Br. J. Psychiatry, 159, 645-653.
11. Eaton, W.W., Hall, A.L., Macdonald, R. and McKibben, J. (2007) Case identification in psychiatric epidemiology: a review. Int. Rev. Psychiatry, 19, 497-507.
12. Phillips, M.R., Zhang, J., Shi, Q. et al. (2009). Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: An epidemiological survey. Lancet, 373 (9680), 2041-2053.
13. Eaton, W. (1985) The epidemiology of schizophrenia. Epidemiol. Rev., 7, 105-126.
14. Berkson, J. (1946) Limitations of the application of fourfold table analysis to hospital data. Biometrics, 2, 37-43.
15. Saha, S., Barendregt, J.J., Vos, T. et al. (2008) Modelling disease frequency measures in schizophrenia epidemiology. Schizophr. Res., 104, 246-254.
16. Eaton, W. (1991) Update on the epidemiology of schizophrenia. Epidemiol. Rev., 13, 320-328.
17. Goldner, E.M., Hsu, L., Waraich, P. and Somers, J.M. (2002) Prevalence and incidence studies of schizophrenic disorders: a systematic review of the literature. Can. J. Psychiatry, 47, 833-843.
18. Jeffreys, S.E., Harvey, C.A., McNaught, A.S. et al. (1997) The Hampstead Schizophrenia Survey 1991. I: Prevalence and service use comparisons in an inner London health authority, 1986-1991. Br. J. Psychiatry, 170, 301-306.
19. McNaught, A.S., Jeffreys, S.E., Harvey, C.A. et al. (1997) The Hampstead Schizophrenia Survey 1991. II: Incidence and migration in inner London. Br. J. Psychiatry, 170, 307-311.
20. de Salvia, D., Barbato, A,. Salvo, P. and Zadro, F. (1993) Prevalence and incidence of schizophrenic disorders in Portogruaro. An Italian case register study. J. Nerv. Ment. Dis., 181(5), 275-282.
21. Saha, S., Chase, D., Welham, J. and McGrath, J. (2005) A systematic review of the prevalence of schizophrenia. PLoS Med., 2, 413-433.
22. McGrath, J., Saha, S., Chant, D. and Welham,J. (2008) The epidemiology of schizophrenia: a concise overview of incidence, prevalence and mortality. Epidemiol. Rev., 30, 67-76.
23. Eaton, W.W. (1999) Evidence for universality and uniformity of schizophrenia around the world: assessment and implications, in Search for the Causes of Schizophrenia, IV. Balance of the Century (eds W. Gattaz and H. Hafner), Steinkopf, Darmstadt, pp. 21-33.
24. Sartorius, N., Jablensky, A., Korten, A. et al. (1986) Early manifestations and first-contact incidence of schizophrenia in different cultures. Psychol. Med., 16, 909-928.
25. Beiser, M., Erickson, D. and Fleming, J.A.E. (1993) Establishing the onset of psychotic illness. Am. J. Psychiatry, 150, 1349-1354.
26. Rajkumar, S., Padmavati, R., Thara, R. and Sarada Menon, M. (1993) Incidence of schizophrenia in an urban community in Madras. Indian J. Psychiatry, 35, 18-21.
27. Saha, S., Welham, J., Chant, D. et al. (2006) Incidence of schizophrenia does not vary with economic status of the country: evidence from a systematic review. Soc. Psychiatry. Psychiatr. Epidemiol., 41, 338-340.
28. Tohen, M., Frank E., Bowden, C.L. et al. (2009) The International Society for Bipolar Disorders (ISBP) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord., 11, 453-473.
29. Hafner, H., Maurer, K., Loffler, W. et al. (1999) Onset and prodromal phase as determinants of the course, in Search for the Causes of Schizophrenia: Vol. IV-Balance of the Century (eds W.F. Gattaz and H. Hafner), Springer, Steinkopf/Darmstadt, pp. 35-58.
30. Ciompi, L. (1980) The natural history of schizophrenia in the long term. Br. J. Psychiatry, 136, 413-420.
31. Mortensen, P.B. and Eaton, W.W. (1994) Predictors for readmission risk in schizophrenia. Psychol.Med., 24, 223-232.
32. Eaton, W.W. (1974) Mental hospitalization as a reinforcement process. Am. Sociol. Rev., 39, 252-260.
33. Cohen, P. and Cohen, J. (1984) The Clinician's Illusion. Arch. Gen. Psychiatry, 41, 1178-1182.
34. Ram, R., Bromet, E.J., Eaton, W.W. et al. (1992) The natural course of schizophrenia: a review of first admission studies. Schizophr. Bull., 18, 185-207.
35. World Health Organization (1979) Schizophrenia: An International Follow-up Study, John Wiley & Sons, Inc., New York.
36. Leff, J., Sartorius, N., Jablensky, A. et al. (1992) The international pilot study of schizophrenia: five year followup findings. Psychol. Med., 22, 131-145.
37. Hopper, K. and Wanderling, J. (2000) Revisiting the developed versus developing country distinction in course and outcome in schizophrenia: results from ISoS, theWHOcollaborative followup project. International Study of Schizophrenia. Schizophr. Bull., 26, 835-846.
38. Harrison, G., Hopper, K., Craig, T. et al. (2001) Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br. J. Psychiatry, 178, 506-517.
39. Malla, A. and Payne, J. (2005) First-episode psychosis: psychopathology, quality of life, and functional outcome. Schizophr. Bull., 31, 650-671.
40. Hegarty, J.D., Baldessarini, R.J., Tohen, M. et al. (1994) One hundred years of schizophrenia: a metaanalysis of the outcome literature. Am. J. Psychiatry, 151, 1409-1416.
41. Menezes, N.M., Arenovich, T. and Zipursky, R.B. (2006) A systematic review of longitudinal outcome studies of first-episode psychosis. Psychol. Med., 36, 1349-1362.
42. Bromet, E.J., Naz, B., Fochtmann, L.J. et al. (2005) Long-term diagnostic stability and outcome in recent first-episode cohort studies of schizophrenia. Schizophr. Bull., 31, 639-649.
43. Saha, S., Chant, D. and McGrath, J. (2007) A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch. Gen. Psychiatry, 64, 1123-1131.
44. Thorup, A., Waltoft, B.L., Pedersen, C.B. et al. (2007) Young males have a higher risk of developing schizophrenia: a Danish register study. Psychol. Med., 37, 479-484.
45. Kirkbride, J.B., Fearon, P., Morgan, C. et al. (2006) Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center æSOP study. Arch. Gen. Psychiatry, 63, 250-258.
46. Aleman, A., Kahn, R.S. and Selten, J.-P. (2003) Sex differences in the risk of schizophrenia: evidence from a meta-analysis. Arch. Gen. Psychiatry, 60, 565-571.
47. McGrath, J., Saha, S., Welham, J. et al. (2004) A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med., 2, 13.
48. Stromgren, E. (1987) Changes in the incidence of schizophrenia? Br. J. Psychiatry, 150, 1-7.
49. Agerbo, E., Byrne, M., Eaton, W. et al. (2004) Marital and labor market status in the long run in schizophrenia. Arch. Gen. Psychiatry, 61, 28-33.
50. Mishler, E.G. and Scotch, N.A. (1963) Sociocultural factors in the epidemiology of schizophrenia. Psychiatry, 26, 313-351.
51. Commission on Lunacy, 1 (1971) Report on Insanity and Idiocy in Massachusetts, Harvard University Press, Boston.
52. Dohrenwend, B.P. and Dohrenwend, B.S. (1969) Social Status and Psychological Disorder: A Causal Inquiry, John Wiley & Sons, Inc., New York.
53. Dohrenwend, B.P., Levav, I., Shrout, P.E. et al. (1992) Socioeconomic status and psychiatric disorders: the causation-selection issue. Science, 255, 946-952.
54. Goldberg, E.M. and Morrison, S.L. (1963) Schizophrenia and social class. Br. J. Psychiatry, 109, 785-802.
55. Turner, R.J. and Wagenfeld, M.O. (1967) Occupational mobility and schizophrenia. Am. Sociol. Rev., 32, 104-113.
56. Byrne, M., Agerbo, E., Eaton, W.W. andMortensen, P.B. (2004) Parental socio-economic status and risk of first admission with schizophrenia-a Danish national register based study. Soc. Psychiatry. Psychiatr. Epidemiol., 39, 87-96.
57. Eaton, W.W. and Harrison, G. (2000) Ethnic Disadvantage and schizophrenia. Acta Psychiatr. Scand., Suppl., 102, 38-43.
58. Selten, J.P., Veen, N., Feller, W., et al. (2001) Incidence of psychotic disorders in immigrant groups to the Netherlands. Br. J. Psychiatry, 178, 367-372.
59. Selten, J.P., Cantor-Graae, E., Slaets, J. and Kahn, R.S. (2002) Odegaard's selection hypothesis revisited: schizophrenia in Surinamese immigrants to The Netherlands. Am. J. Psychiatry, 159 (4), 669-671.
60. Fearon, P. and Morgan, C. (2006) Environmental factors in schizophrenia: the role of migrant studies. Schizophr. Bull, 32 (3), 405-408.
61. Kirkbride, J.B., Barker, D., Cowden, F. et al. (2008) Psychoses, ethnicity and socio-economic status. Br. J. Psychiatry, 193, 18-24.
62. Morgan, C., Dazzan, P., Morgan, K. et al. (2006) First episode psychosis and ethnicity: initial findings from the æSOP study. World Psychiatry, 5, 40-46.
63. Coid, J.W., Kirkbride, J.B., Barker, D. et al. (2008) Raised incidence rates of all psychoses among migrant groups: findings from the East London first episode psychosis study. Arch. Gen. Psychiatry, 65, 1250-1258.
64. Eaton, W.W. and Harrison, G. (2001) Life chances, life planning, and schizophrenia: a review and interpretation of research on social deprivation. Int. J. Ment. Health, 30, 58-81.
65. Warner, R. (1995) Time trends in schizophrenia: changes in obstetric risk factors with industrialization. Schizophr. Bull., 21, 483-500.
66. McGrath, J. (1999) Hypothesis: is low prenatal vitamin D a risk-modifying factor for schizophrenia? Schizophr. Res., 40, 173-177.
67. Kinney, D.K., Teixeira, P.,Hsu,D. et al. (2009) Relation of schizophrenia prevalence to latitude, climate, fish consumption, infant mortality, and skin color: a role for prenatal vitamin d deficiency and infections? Schizophr. Bull., 35, 582-595.
68. Faris, R.E. and Dunham, W. (1939) Mental Disorders in Urban Areas, University of Chicago Press, Chicago.
69. Eaton, W.W. (1974b) Residence, social class, and schizophrenia. J. Health Soc. Behav., 15, 289-299.
70. Lewis, G., David, A. and Andreasson, S.A.P. (1992) Schizophrenia and city life. Lancet, 340, 137-140.
71. Marcelis, M., Navarro-Mateu, F., Murray, R. et al. (1998) Urbanization and psychosis: a study of 1942-1978 birth cohorts in The Netherlands. Psychol. Med., 28, 871-879.
72. Eaton, W.W., Mortensen, P.B. and Frydenberg, M. (2000) Obstetric complications, urbanization, and psychosis. Schizophr. Res., 43, 117-123.
73. McCreadie, R.G. (1997) The Nithsdale Schizophrenia Surveys 16: Breast-feeding and schizophrenia: preliminary results and hypotheses. Br. J. Psychiatry, 170, 334-337.
74. Torrey, E. and Yolken, R. (1995) Could schizophrenia be a viral zoonosis transmitted from house cats? Schizophr. Bull., 21, 167-171.
75. Torrey, E.F. and Yolken, R.H. (1998) Is household crowding a risk factor for schizophrenia?. Schizophr. Res., 29, 12-13.
76. Van Os, J., Pedersen, C.B. and Mortensen, P.B. (2004) Confirmation of synergy between urbanicity and familial liability in the causation of psychosis. Am. J. Psychiatry, 161, 2312-2314.
77. Torrey, E.F. and Miller, J. (2001) The Invisible Plague: The Rise ofMental Illness From 1750 to The Present, Rutgers University Press, New Brunswick, NJ.
78. Jablensky, A. (1995) Schizophrenia: recent epidemiologic issues. Epidemiol. Rev., 17, 10-20.
79. Oldehinkel, A.J. and Giel, R. (1995) Time trends in the care-based incidence of Schizoprenia. Br. J. Psychiatry, 167, 777-782.
80. Suvisaari, J.M., Haukka, J.K., Tanskanen, A.J. et al. (1999) Decline in the incidence of schizophrenia in Finnish cohorts born from 1954 to 1965. Arch. Gen. Psychiatry, 56, 733-740.
81. Allardyce, J., Morrison, G., Van Os, J. et al. (2000) Schizophrenia is not disappearing in south-west Scotland. Br. J. Psychiatry, 177, 38-41.
82. Goldhammer, H. and Marshall, A.W. (1953) Psychosis and Civilization: Two Studies in the Frequency of Mental Disease, Free Press, New York.
83. Eaton, W. (2001) The Sociology of Mental Disorders. Praeger Publishers, Westport, CT.
84. Hall, W. and Degenhardt, L. (2000) Cannabis use and psychosis: a review of clinical and epidemiological evidence. Aust.N. Z. J. Psychiatry, 34, 26-34.
85. Arsenault, L., Cannon, M., Poulton, R. et al. (2002) Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. Br. J. Med., 325, 1212-1213.
86. Van Os, J., Bak, M., Hanssen, M. et al. (2002) Cannabis use and psychosis: a longitudinal population-based study. Am. J. Epidemiol., 156, 319-327.
87. Zammit, S., Allebeck, P., Andreasson, S. et al. (2002) Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. Br. J. Med., 325, 1199.
88. Weiser, M., Reichenberg, A., Rabinowitz, J. et al. (2003) Self-reported drug abuse in male adolescents with behavioral disturbances, and follow-up for future schizophrenia. Biol. Psychiatry, 54, 655-660.
89. Moore, T.H., Zammit, S., Lingford-Hughes, A. et al. (2007) Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet, 370, 319-328.
90. Foti, D., Kotov, R., Guey, L.T. and Bromet, E.J. (2010) Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization. Am. J. Psychiatry, 167987-167993.
91. Rais, M., Cahn, W., Van, H.N. et al. (2008) Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients. Am. J. Psychiatry, 165, 490-496.
92. Kendler, K.S. (1988) The Genetics of Schizophrenia, in Handbook of Schizophrenia, Nosology, Epidemiology, and Genetics of Schizophrenia, vol. 3 (eds M.T. Tsuang and J.C. Simpson), Elsevier, Amsterdam, pp. 437-462.
93. Cardno, A.G. and Gottesman, I.I. (2000) Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am. J. Hum. Genet., 97, 12-17.
94. Sullivan, P.F., Owen, M.J., O'Donovan, M.C. et al. (2006) Genetics, in The American Psychiatric Publishing Textbook of Schizophrenia, (eds J.A. Lieberman, T.S. Stroup and D.O. Perkins), American Psychiatric Publishing,Washington, DC, pp. 39-93.
95. Lichtenstein, P., Bjork, C., Hultman, C.M. et al. (2006) Recurrence risks for schizophrenia in a Swedish National cohort. Psychol. Med., 36, 1417-1425.
96. Lichtenstein, P., Yip, B.H., Bjork, C. et al. (2009) Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a populationbased study. Lancet, 373, 234-239.
97. Venter, J.C., Adams, M.D.,Myers, E.W. et al. (2001) The sequence of the human genome. Science, 291, 1304-1351.
98. Lewis, C.M., Levinson, D.F.,Wise, L.H. et al. (2003) Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am. J. Hum. Genet., 73, 34-48.
99. Ng, M.Y., Levinson, D.F., Faraone, S.V. et al. Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol. Psychiatry.
100. Allen, N.C., Bagade, S., McQueen, M.B. et al. (2008) Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat. Genet., 40, 827-834.
101. Edwards, T.L., Wang, X., Chen, Q. et al. (2008) Interaction between interleukin 3 and dystrobrevinbinding protein 1 in schizophrenia. Schizophr. Res., 106, 208-217.
102. Guo, A.Y., Sun, J., Riley, B.P. et al. (2009) The dystrobrevin-binding protein 1 gene: features and networks. Mol. Psychiatry, 14, 18-29.
103. McCarroll, S.A. (2008) Extending genome-wide association studies to copy-number variation. Hum. Mol. Genet., 17, R135-R142.
104. Hennah, W., Varilo, T., Paunio, T. et al. (2004) Haplotype analysis and identification of genes for a complex trait: examples from schizophrenia. Ann. Med., 36, 322-331.
105. Van Os, J., Rutten, B.P. and Poulton, R. (2008) Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophr. Bull., 34, 1066-1082.
106. Gottesman, I.I. and Gould, T.D. (2003) The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry, 160, 636-645.
107. Camargo, L.M., Collura, V., Rain, J.C. et al. (2007) Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia. Mol. Psychiatry, 12, 74-86.
108. Lewis, M.S. (1989) Age incidence and schizophrenia: part I. The season of birth controversy. Schizophr. Bull., 15, 59-73.
109. Davies, G., Welham, J., Chant, D. et al. (2003) A systematic review and meta-analysis of Northern Hemisphere season of birth studies in schizophrenia. Schizophr. Bull., 29, 587-593.
110. Messias, E.L.M., Cordeiro, N.F., Sampaio, J.J.C. et al. (2001) Schizophrenia and season of birth in a tropical region: relationship to rainfall. Schizophr. Res., 48, 227-234.
111. Torrey, E.F., Miller, J., Rawlings, R. and Yolken, R.H. (1997) Seasonality of births in schizophrenia and bipolar disorder: a review of the literature. Schizophr. Res., 28(1), 1-38.
112. Mortensen, P.B., Pedersen, C.B., Westergaard, T. et al. (1999) Familial and non-familial risk factors for schizophrenia: a population-based study. N. Engl. J. Med., 340, 603-608.
113. Gregory, I. (1959) An analysis of family data on 1000 patients admitted to a Canadian mental hospital. Acta Genet. Stat. Med., 9, 54-96.
114. Granville-Grossman, K.L. (1966) Parental age and schizophrenia. Br. J. Psychiatry, 112, 899-905.
115. Hare, E.H. and Moran, P.A. (1979) Raised parental age in psychiatric patients: evidence for the constitutional hypothesis. Br. J. Psychiatry, 134, 169-177.
116. Kinnell, H.G. (1983) Parental age in schizophrenia. Br. J. Psychiatry, 142, 204.
117. Malaspina, D., Harlap, S., Fennig, S. et al. (2001) Advancing paternal age and the risk of schizophrenia. Arch. Gen. Psychiatry, 58, 361-367.
118. Brown, A.S., Schaefer, C.A.,Wyatt, R.J. et al. (2002) Paternal age and risk of schizophrenia in adult offspring. Am. J. Psychiatry, 159, 1528-1533.
119. Dalman, C. and Allebeck, P. (2002) Paternal age and schizophrenia: further support for an association. Am. J. Psychiatry, 159, 1591-1592.
120. Malaspina, D., Corcoran, C., Fahim, C. et al. (2002) Paternal age and sporadic schizophrenia: evidence for de novo mutations. Am. J. Med. Genet., 114, 299-303.
121. Byrne, M., Agerbo, E., Ewald, H. et al. (2003) Parental age and risk of schizophrenia: a case-control study. Arch. Gen. Psychiatry, 60, 673-678.
122. Zammit, S., Allebeck, P., Dalman, C. et al. (2003) Paternal age and risk for schizophrenia. Br. J. Psychiatry, 183, 405-408.
123. Crow, J.F. (2000) The origins, patterns and implications of human spontaneous mutation. Nat. Rev. Genet., 1, 40-47.
124. Malaspina, D. (2001) Paternal factors and schizophrenia risk: de novo mutations and imprinting. Schizophr. Bull., 27, 379-393.
125. Huttunen, M.O. and Niskanen, P. (1978) Prenatal loss of father and psychiatric disorders. Arch. Gen. Psychiatry, 35, 429-431.
126. Geddes, J.R. and Lawrie, S.M. (1995) Obstetric complications and schizophrenia: a meta-analysis. Br. J. Psychiatry, 167, 786-793.
127. Verdoux, H., Geddes, J.R., Takei, N. et al. (1997) Obstetric complications and age at onset in schizophrenia: an international collaborative metaanalysis of individual patient data. Am. J. Psychiatry, 154, 1220-1227.
128. Geddes, J.R., Verdoux, H., Takei, N. et al. (1999) Schizophrenia and complications of pregnancy and labor: an individual patient data meta-analysis. Schizophr. Bull., 25, 413-423.
129. Cannon, M., Jones, P.B. and Murray, R.M. (2002b) Obstetric complications and schizophrenia: historical and meta-analytic review. Am. J. Psychiatry, 159, 1080-1092.
130. Dalman, C., Allebeck, P., Cullberg, J. et al. (1999) Obstetric complications and the risk of schizophrenia: a longitudinal study of a national birth cohort. Arch. Gen. Psychiatry, 56, 234-240.
131. Rosso, I.M., Cannon, T.D., Huttunen, T. et al. (2000) Obstetric risk factors for early-onset schizophrenia in a Finnish birth cohort. Am. J. Psychiatry, 157, 801-807.
132. Zornberg, G.L., Buka, S.L. and Tsuang,M.T. (2000) Hypoxic-ischemia-related fetal/neonatal complications and risk of schizophrenia and other nonaffective psychoses: a 19-year longitudinal study. Am. J. Psychiatry, 157, 196-202.
133. Susser, E.S. and Lin, S.P. (1992) Schizophrenia after prenatal exposure to the Dutch hunger winter of 1944-1945. Arch. Gen. Psychiatry, 49, 983-988.
134. St Clair, D., Xu, M., Wang, P. et al. (2005) Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959-1961. J. Am. Med. Assoc., 294, 557-562.
135. Khashan, A.S., Abel, K.M., McNamee, R. et al. (2008) Higher risk of offspring schizophrenia following antenatal maternal exposure to severe adverse life events. Arch. Gen. Psychiatry, 65, 146-152.
136. Insel, B.J., Schaefer, C.A., McKeague, I.W. et al. (2008) Maternal iron deficiency and the risk of schizophrenia in offspring. Arch. Gen. Psychiatry, 65, 1136-1144.
137. Mittal, V.A., Ellman, L.M. and Cannon, T.D. (2008) Gene-environment interaction and covariation in schizophrenia: the role of obstetric complications. Schizophr. Bull., 34, 1083-1094.
138. Lane, A., Kinsella, A., Murphy, P. et al. (1997) The anthropometric assessment of dysmorphic features in schizophrenia as an index of its developmental origins. Psychol. Med., 27, 1155-1164.
139. Ismail, B., Cantor-Graae, E. and McNeil, T.F. (1998) Minor physical anomalies in schizophrenic patients and their siblings. Am. J. Psychiatry, 155, 1695-1702.
140. Ismail, B., Cantor-Graae, E. and McNeil, T.F. (2000) Minor physical anomalies in schizophrenia: cognitive, neurological and other clinical correlates. J. Psychiatr. Res., 34, 45-56.
141. Schiffman, J., Ekstrom, M., LaBrie, J. et al. (2002) Minor physical anomalies and schizophrenia spectrum disorders: a prospective investigation. Am. J. Psychiatry, 159, 238-243.
142. Weinberg, S.M., Jenkins, E.A., Marazita, M.L. et al. (2007) Minor physical anomalies in schizophrenia: a meta-analysis. Schizophr. Res., 89, 72-85.
143. Waldrop M.F., Pedersen, F.A. and Bell, R.Q. (1968) Minor physical anomalies and behavior in preschool children. Child Dev., 39(2), 39.
144. McNeil, T.F. and Cantor-Graae, E. (2000) Minor physical anomalies and obstetric complications in schizophrenia. Aust.N. Z. J. Psychiatry. 34 (Suppl), 65-73.
145. Tarrant, C.J. and Jones, P.B. (1999) Precursors to schizophrenia: do biological markers have specificity?. Can. J. Psychiatry, 44, 335-349.
146. Cannon, T.D., van Erp, T.G., Bearden, C.E. et al. (2003) Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions. Schizophr. Bull., 29, 653-669.
147. Niemi L.T. Suvisaari, J.M., Tuulio-Henriksson, A. et al. (2003) Childhood developmental abnormalities in schizophrenia: evidence from high-risk studies. Schizophr. Res., 60, 239-258.
148. Jones, P., Rodgers, B.,Murray, R. et al. (1994) Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet, 344, 1398-1402.
149. Jones, P. (1997) The early origins of schizophrenia. Br. Med. Bull., 53, 135-155.
150. Isohanni, M., Jones, P.B., Moilanen, K. et al. (2001) Early developmental milestones in adult schizophrenia and other psychoses. A 31-year follow-up of the Northern Finland 1966 Birth Cohort. Schizophr. Res., 52, 1-19.
151. David, A.S., Malmberg, A., Brandt, L. et al. (1997) IQ and risk for schizophrenia: a population-based cohort study. Psychol. Med., 27, 1311-1323.
152. Gunnell, D., Harrison, G., Rasmussen, F. et al. (2002) Associations between premorbid intellectual performance, early-life exposures and early-onset schizophrenia. Cohort study. Br. J. Psychiatry, 181, 298-305.
153. Done, D.J., Crow, T.J., Johnstone, E.C. et al. (1994) Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. Br. J. Med., 309, 699-703.
154. Isohanni, I., Jarvelin, M.R., Nieminen, P. et al. (1998) School performance as a predictor of psychiatric hospitalization in adult life. A 28-year follow-up in the Northern Finland 1966 Birth Cohort. Psychol. Med., 28, 967-974.
155. Cannon, M., Jones, P., Huttunen, M.O. et al. (1999a) School performance in Finnish children and later development of schizophrenia: a populationbased longitudinal study. Arch. Gen. Psychiatry, 56, 457-463.
156. Cannon, T.D., Rosso, I.M., Bearden, C.E. et al. (1999b) A prospective cohort study of neurodevelopmental processes in the genesis and epigenesis of schizophrenia. Dev. Psychopathol., 11, 467-485.
157. Cannon, M., Caspi, A., Moffitt, T.E. et al. (2002a) Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch. Gen. Psychiatry, 59, 449-456.
158. Leask, S.J., Done, D.J. and Crow, T.J. (2002) Adult psychosis, common childhood infections and neurological soft signs in a national birth cohort. Br. J. Psychiatry, 181, 387-392.
159. Malmberg, A., Lewis, G., David, A. et al. (1998) Premorbid adjustment and personality in people with schizophrenia. Br. J. Psychiatry, 172, 308-313.
160. Koenen, K.C., Moffitt, T.E., Roberts, A.L., et al. (2009) Childhood IQ and adult mental disorders: A test of the cognitive reserve hypothesis. Am. J. Psychiatry, 166 (1), 50-57.
161. Mednick, S., Machon, R.A., Huttunen, M.O. and Bonett, D. (1988) Adult Schizophrenia following prenatal exposure to an influenza epidemic. Arch. Gen. Psychiatry, 45, 189-192.
162. Munk-Jorgensen, P. and Ewald, H. (2001) Epidemiology in neurobiological research: exemplified by the influenza-schizophrenia theory. Br. J. Psychiatry Suppl., 40, 30-32.
163. Brown, A.S. and Susser, E.S. (2002) In utero infection and adult schizophrenia. Ment. Retard. Dev. Disabil. Res. Rev., 8, 51-57.
164. Murray, R.M. (1987) Is schizophrenia a neurodevelopmental disorder?. Br. J. Med., 295, 681-682.
165. Weinberger, D.R. (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry, 44, 660-669.
166. Yolken, R.H. and Torrey, E.F. (1995) Viruses, schizophrenia, and bipolar disorder. Clin.Microbiol. Rev., 8, 131-145.
167. Brown, A.S., Schaefer, C.A., Quesenberry, C.P.Jr . et al. (2005) Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am. J. Psychiatry, 162, 767-773.
168. Torrey, E.F. and Yolken, R.H. (2003) Toxoplasma gondii and schizophrenia. Emerg. Infect. Dis., 9, 1375-1380.
169. Brown, A.S., Cohen, P., Greenwald, S. and Susser, E. (2000) Nonaffective psychosis after prenatal exposure to rubella. Am. J. Psychiatry, 157, 438-443.
170. Buka, S.L., Tsuang, M.T., Torrey, E.F. et al. (2001) Maternal infections and subsequent psychosis among offspring. Arch. Gen. Psychiatry, 58, 1032-1037.
171. Buka, S.L., Cannon, T.D., Torrey, E.F. et al. (2008) Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring. Biol. Psychiatry, 63, 809-815.
172. Gattaz, W.F., Abrahao, A.L. and Foccacio, R. (2004) Childhood meningitis, brain maturation, and the risk of psychosis. Eur. Arch. Psychiatry. Clin. Neurosci., 254, 23-26.
173. Vita, A., De, P.L., Silenzi, C. et al. (2006) Brain morphology in first-episode schizophrenia: a metaanalysis of quantitative magnetic resonance imaging studies. Schizophr. Res., 82, 75-88.
174. Steen, R.G., Mull, C., McClure, R. et al. (2006) Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br. J. Psychiatry, 188, 510-518.
175. Rijsdijk, F.V., van Haren, N.E., Picchioni, M.M. et al. (2005) BrainMRI abnormalities in schizophrenia: same genes or same environment?. Psychol.Med., 35, 1399-1409.
176. Eaton, W.W., Day, R. and Kramer, M. (1988) The uses of epidemiology for risk factor research in schizophrenia: an overview and methodologic critique, in Handbook of Schizophrenia, Nosology, Epidemiology and Genetics, vol. 3 (eds M. Tsuang and J. Simpson), Elsevier, Amsterdam.
177. Eaton, W., Hayward, C. and Ram, R. (1992) Schizophrenia and rheumatoid arthritis: a review. Schizophr. Res., 6, 181-192.
178. McLaughlin, D. (1977) Racial and sex differences in length of hospitalization of schizophrenics. Sixth World Congress of Psychiatry, Honolulu, HI.
179. Eaton, W.W., Byrne, M., Ewald, H. et al. (2006) Association of schizophrenia and autoimmune diseases: Linkage of Danish National Registers. Am. J. Psychiatry, 163, 521-528.
180. in' t Veld, B.A., Launer, L.J., Breteler, M.M. et al. (2002) Pharmacologic agents associated with a preventive effect on Alzheimer's disease: a review of the epidemiologic evidence. Epidemiol. Rev., 24, 248-268.
181. Etminan M. Gill, S. and Samii, A. (2003) Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and metaanalysis of observational studies. Br. J. Med., 327, 128.
182. Gilvarry, C.M., Sham, P.C., Jones, P.B. et al. (1996) Family history of autoimmune diseases in psychosis. Schizophr. Res., 19, 33-40.
183. Wright, P., Sham, P.C., Gilvarry, C.M. et al. (1996) Autoimmune diseases in the pedigrees of schizophrenic and control subjects. Schizophr. Res., 20, 261-267.
184. DeLisi, L.E., Boccio, A.M., Riordan, H. et al. (1991) Familial thyroid disease and delayed language development in first admission patients with schizophrenia. Psychiatry Res., 38, 39-50.
185. Kalaydjian, A.E., Eaton, W., Cascella, N. et al. (2006) The gluten connection: the association between schizophrenia and celiac disease. Acta Psychiatr. Scand., 113, 82-90.
186. Eaton, W.W., Mortensen, P.B., Agerbo, E. et al. (2004) Coeliac disease and schizophrenia: population based case control study with linkage of Danish national registers. Br. J. Med., 328, 438-439.
187. Cascella, N.G., Kryszak, D., Bhatti, B. et al. (2009) Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population. Schizophr. Bull.
188. Dohan, F. (1980) Celiac disease and schizophrenia. N. Engl. J. Med., 1262.
189. Ganguli, R., Brar, J., Chengappa, K. et al. (1993) Autoimmunity in schizophrenia: a review of recent findings. Ann. Med., 25, 489-496.
190. Ganguli, R., Brar, J. and Rabin, B. (1994) Immune abnormalities in schizophrenia: evidence for the autoimmune hypothesis. Harv. Rev. Psychiatry, 2, 70-83.
191. Rothermundt, M., Arolt, V. and Bayer, T.A. (2001) Review of immunological and immunopathological findings in schizophrenia. Brain Behav. Immun., 15, 319-339.
192. Muller, N., Riedel, M., Scheppach, C. et al. (2002) Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. Am. J. Psychiatry, 159, 1029-1034.
193. Dickerson, F.B., Boronow, J.J., Stallings, C.R. et al. (2003) Reduction of symptoms by valacyclovir in cytomegalovirus-seropositive individuals with schizophrenia. Am. J. Psychiatry, 160, 2234-2236.
194. Steffansson, H.,Ophoff, R.A., Steinberg, S. Common variants conferring risk of schizophrenia, Nature, in press.
195. Klosterkotter, J., Hellmich, M., Steinmeyer, E.M. et al. (2001) Diagnosing schizophrenia in the initial prodromal phase. Arch. Gen. Psychiatry, 58, 158-164.
196. Miller, T.J., McGlashan, T.H., Rosen, J.L. et al. (2003) Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr. Bull., 29, 703-715.
197. Cannon, T.D., Cadenhead, K., Cornblatt, B. et al. (2008) Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch. Gen. Psychiatry, 65, 28-37.
198. Woods, S.W., Addington, J., Cadenhead, K.S. et al. (2009) Validity of the prodromal risk syndrome for first psychosis: findings from the North American prodrome longitudinal study. Schizophr. Bull.
199. Cornblatt, B.A., Lencz, T. and Kane, J.M. (2001) Treatment of the schizophrenia prodrome: is it presently ethical?. Schizophr. Res., 51, 31-38.
200. Cornblatt, B.A., Lencz, T., Smith, C.W. et al. (2007) Can antidepressants be used to treat the schizophrenia prodrome?. Results of a prospective, naturalistic treatment study of adolescents. J. Clin. Psychiatry, 68, 546-557.
201. McGorry, P.D.E.J. and Mihaloppoulos, C. (1996) EPPIC: an evolving system of early detection and optimal management. Schizophr. Bull., 22, 305-326.
202. Tsuang, M.T., Stone, W.S., Seidman, L.J. et al. (1999) Treatment of nonpsychotic relatives of patients with schizophrenia: four case studies. Biol. Psychiatry, 45, 1412-1418.
203. Woods, S.W., Breier, A., Zipursky, R.B. et al. (2003) Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome. Biol. Psychiatry, 54, 453-464.
204. Yung, A.R., Killackey, E., Hetrick, S.E. et al. (2007) The prevention of schizophrenia. Int. Rev. Psychiatry, 19, 633-646.